SaNOtize’s Nitric Oxide Nasal Spray is approved as a medical device in Thailand, Singapore, Hong Kong, Nepal, South Africa, Germany (branded as VirXTM), Israel, Indonesia and Bahrain (branded as enovidTM).
It is also available in India, with prescription, under the name FabiSpray.
It is not yet approved for sale in Canada or the United States.
VirXTM and enovidTM are identical formulations based on our NORSTM (Nitric Oxide Releasing Solution) platform technology. They have the same active ingredients and mechanisms of action as those nasal therapeutics used in our clinical trials.
For more information on VirXTM and enovidTM please visit this page.